Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Identifying which credit card has the best benefits can enhance your financial strategy. Discover top picks to optimize your rewards and savings.
27,965 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Berkshire Hathaway reports a record cash and Treasury position, signaling Buffett’s readiness to act when markets dis...
A new income-focused ETF challenger has pushed past JEPI by roughly 42 percentage points since its October 2023 debut...
A tech sector retreat has pulled many chip names lower, but weakness can create entry points. Here are three beaten-d...
Solana leads in current on-chain activity as of mid-May 2026, with XRP showing growing throughput and Cardano lagging...
Dell Technologies leads the pack in 2026 among AI server stocks, outpacing Hewlett Packard Enterprise and Super Micro...
When choosing between Invesco's PPA and State Street's XAR, you’re weighing volatility, diversification, and exposure...
Forward Air’s path to 2025 earnings rests on freight demand, margins, and disciplined cost management. This guide bre...
A thorough look at Novanta's Q1 2026 results and what they signal for novanta (novt) 2026 earnings. We break down rev...
As investors assess concentrix (cnxc) 2026 earnings, this guide breaks down what to watch, how margins may move, and ...
When a local emergency provider faces a court case over funds, it isn’t just a headline—it can affect budgets, bills,...
As orthofix prepares its 2025 earnings narrative, investors weigh product mix shifts, margins, and macro headwinds. T...